CROI 2019 Program and Conference Information

Oral Sessions

84 LB QT EFFECTS OF BEDAQUILINE, DELAMANID OR BOTH INMDR-TB PATIENTS: THE DELIBERATE TRIAL Kelly E. Dooley, Susan L. Rosenkranz, Francesca Conradie, Laura E. Moran, Richard Hafner, Florian von Groote-Bidlingmaier, Javier R. Lama, Justin Shenje, Kyla Comins, Joel Morganroth, Andreas H. Diacon, Yoninah S. Cramer, Kathleen M. Donahue, Gary Maartens, for the ACTG A5343 Study Team Oral Abstract O-08 HEPATITIS C: NOW YOU SEE ME; SOON YOUWON’T Room 6C 10:00 AM - 12:00 PM Oral Abstract Moderators Jennifer Price, University of California San Francisco, San Francsico, CA, USA Gilles Wandeler, Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland 85 FALL INHCV INCIDENCE INHIV+MSM IN LONDON FOLLOWING WIDER ACCESS TO DAA THERAPY Lucy J. Garvey, Colette J. Smith, Christof Stingone, Indrajit Ghosh, Alison Rodger, Lakshmi Jain, Chandni Sood, Tabitha Mahungu, Carolyn Freeman, Subathira Dakshina, Filippo Ferro, Laura Waters, Ashley Brown, Graham S. Cooke, Sanjay Bhagani HCV REINFECTION AMONG HIV-INFECTEDMSM INNEWYORK CITY Jesse R. Carollo, Stephanie H. Factor, Gabriela Rodriguez-Caprio, Asa Radix, Stephen M. Dillon, Rona Vail, Krisczar J. Bungay, Robert Chavez, José Lares- Guia, Daniel S. Fierer, for the New York Acute Hepatitis C Surveillance Network A PHASE 1 STUDY OF LEDIPASVIR/SOFOSBUVIR IN PREGNANT WOMENWITHHEPATITIS C VIRUS Catherine A. Chappell, Elizabeth E. Krans, Katherine Bunge, Ingrid Macio, Debra Bogen, Kimberly K. Scarsi, Leslie A. Meyn, Sharon L. Hillier 11:45 10:00 10:15 10:30 86 87 INCIDENT DIABETES AND GLUCOSE CONTROL AFTER HCV TREATMENTWITH DAAs IN ERCHIVES Adeel A. Butt, Samia Aslam, Peng Yan, Obaid S. Shaikh, Abdul-Badi Abou-Samra INTRAHEPATIC HEPATITIS C KINETICSWITH DIRECT-ACTING ANTIVIRALS INHIV COINFECTION Ashwin Balagopal, Laura M. Smeaton, Vincent Vu, Charles S. Venuto, Gene D. Morse, Beverly Alston-Smith, Daniel E. Cohen, Jorge L. Santana, Donald D. Anthony, Mark Sulkowski, David L. Wyles, Andrew H. Talal, for the ACTG A5335S Substudy Team HIV VIREMIA AND LOWCD4+ INCREASE HCC RISK IN THOSE WITHOUT ADVANCED LIVER FIBROSIS Jessie Torgersen, Michael J. Kallan, Dena M. Carbonari, Jason A. Roy, Lesley S. Park, Tamar Taddei, Rajni Mehta, Kathyrn D’Addeo, Joseph Lim, Matthew B. Goetz, Janet Tate, Norbert Bräu, Amy C. Justice, Vincent Lo Re 91 LB SINGLE HEPATOCYTE ANALYSIS INHIV-HBV COINFECTION SHOWS HBV TRANSCRIPTION SILENCING Ashwin Balagopal, Hyon S. Hwang, Tanner Grudda, Jeffrey Quinn, Richard K. Sterling, Mark Sulkowski, Chloe Thio 10:45 11:00 11:30 89 88

Oral Sessions • Wednesday 90 11:15

CROI 2019 44